Dorsch W, Baur X
Allergy. 1980 Sep;35(6):503-8. doi: 10.1111/j.1398-9995.1980.tb01797.x.
Twelve asthmatics with dual bronchial and skin reactions after allergen challenge received topical treatment with a 5%-indomethacin cream half an hour before and up to 7 h after intradermal allergen and histamine injections. The erythema during the first 20 min of the wheal and flare reaction (WFR) was not affected, neither were the diameters of wheals and flares. 40 to 60 min after injection we observed a marked reduction of the erythema in histamine- and allergen-tested skin areas of 10 patients. This effect lasted up to the 5th h after injection of high allergen doses. During the fully developed late cutaneous reactions (LCR) no effect of indomethacin on the erythema was observed, the edema of LCR was only insignificantly reduced. These results suggest that the erythema in LCR between the 1st and 4th h is caused, at least in part, by local formation of prostaglandins.
12名在变应原激发后出现支气管和皮肤双重反应的哮喘患者,在皮内注射变应原和组胺前半小时至注射后7小时,接受5%吲哚美辛乳膏局部治疗。风团和潮红反应(WFR)最初20分钟内的红斑未受影响,风团和潮红的直径也未受影响。注射后40至60分钟,我们观察到10名患者组胺和变应原检测皮肤区域的红斑明显减轻。高剂量变应原注射后,这种效应持续至第5小时。在完全发展的迟发性皮肤反应(LCR)期间,未观察到吲哚美辛对红斑有影响,LCR的水肿仅略有减轻。这些结果表明,LCR在第1至4小时之间的红斑至少部分是由局部前列腺素形成引起的。